STOCK TITAN

Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX) announced its management team will participate in a fireside chat at Guggenheim Synthetic Lethality Day 2022 on May 16 at 10:00 AM ET. The event will be accessible via a live webcast found on the company's website under the 'Events & Presentations' section. Additionally, a replay will be available for 30 days post-event. The company focuses on developing precision cancer medicines by leveraging synthetic lethality, targeting tumor suppressor gene loss, and enhancing cancer treatments.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in a fireside chat at the Guggenheim Synthetic Lethality Day 2022 on Monday, May 16 at 10:00AM ET.

A live webcast of the event will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 30 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin/Michael Barron
Argot Partners
tango@argotpartners.com

Media Contact:
Joshua R. Mansbach
Argot Partners
tango@argotpartners.com


FAQ

When is the Guggenheim Synthetic Lethality Day 2022 for TNGX?

The Guggenheim Synthetic Lethality Day 2022 will take place on May 16 at 10:00 AM ET.

Where can I watch the TNGX fireside chat?

The TNGX fireside chat can be watched live on the company's website under the 'Events & Presentations' section.

How long will the TNGX webcast be available?

The replay of the TNGX webcast will be available for 30 days after the event.

What is the focus of Tango Therapeutics?

Tango Therapeutics focuses on discovering precision cancer medicines utilizing the genetic principle of synthetic lethality.

Tango Therapeutics, Inc.

NASDAQ:TNGX

TNGX Rankings

TNGX Latest News

TNGX Stock Data

552.87M
107.14M
12.87%
89.59%
8.31%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON